Table: begin end state 1 34 cytoplasmic 35 57 transmembrane 58 68 non-cytoplasmic 69 89 transmembrane 90 112 cytoplasmic 113 134 transmembrane 135 153 non-cytoplasmic 154 173 transmembrane 174 184 cytoplasmic 185 205 transmembrane 206 216 non-cytoplasmic 217 240 transmembrane 241 251 cytoplasmic 252 275 transmembrane 276 303 non-cytoplasmic 304 328 transmembrane 329 347 cytoplasmic 348 368 transmembrane 369 373 non-cytoplasmic 374 392 transmembrane 393 412 cytoplasmic 413 435 transmembrane 436 437 non-cytoplasmic
Input: >WP_012412234.1 NCBI__GCF_000020025.1:WP_012412234.1 MLPIETVLKDSEQVTRLFSHLEFDGKKFNHQPGSVLGSTALIAGTTVGAGILALPAVTLP SGIVPSTSGLIAVWLYALVSGLLVAEVTLNTMRTEGRVSIGFLGVVEKILGKLGAQMAGG AYLFMHYALLVAYITQGGEILGYAAAKIWSVQILPAWMGTTTFTLLFGGIMYLGREKFIE KLNSAFVGIVIVSFFGLLFFAGRHIQSAQLLFQNWSALGSAISVMSVALFFQNVVPLVVT QLEGDAGKIRQSILIGSVIPLIMFLAWNAVILGSISPDMQYGTSDGRTVFDPLQILRAGG AGEWLGVLVSIFSEFAIVTSFIGFVYGLLDLFEDIFLGQSKLSNRFPLYSLVLFPPMTLG TLNPSIFFTALDYTGTFSISVLGGIIPALMSWKQRQEQENSDSTNQLLVPGGKLTLIVMI GVALTMMGRQILVIYTE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server